Jasper Therapeutics Inc. (JSPRW)
NASDAQ: JSPRW
· Real-Time Price · USD
0.09
-0.01 (-14.29%)
At close: Jun 09, 2025, 3:57 PM
Jasper Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -78.78M | -71.27M | -63.53M | -62.44M | -63.93M | -64.47M | -61.09M | -55.41M | -49.74M | -37.69M | -33.53M | -25.08M | -23.09M | -30.64M | -31.57M | -28.17M | -19.76M |
Depreciation & Amortization | 1.36M | 1.37M | 1.41M | 1.15M | 1.12M | 1.11M | 1.1M | 1.09M | 1.03M | 975K | 896K | 760K | 571K | 377K | 183K | 51K | 22K |
Stock-Based Compensation | 7.26M | 6.62M | 5.81M | 5.2M | 5.11M | 5.21M | 5.66M | 4.91M | 4.58M | 4.09M | 2.72M | 2.27M | 1.5M | 1.05M | 1.25M | 1.06M | 764.77K |
Other Working Capital | 1.92M | 73K | -1.17M | -223K | 2.96M | 2.72M | 4.27M | 3.44M | -616K | 1.5M | -3.28M | -1.81M | -807K | -1.32M | 4.66M | 1.56M | 899.68K |
Other Non-Cash Items | 2.21M | 5.85M | 6.62M | 6.07M | 4.01M | 1.81M | 751K | 492K | -565K | -12.59M | -15.46M | -21.23M | -19.77M | -9.09M | -2.04M | 4.22M | 4.14M |
Deferred Income Tax | n/a | n/a | -831K | -831K | -831K | -831K | n/a | n/a | n/a | n/a | -50K | -500K | -500K | 3M | 3.05M | 3.5M | 3.5M |
Change in Working Capital | 3.55M | -49K | -2.3M | 98K | 556K | 5.1M | 5.36M | 3.03M | 2.71M | -649K | -2.37M | -1.48M | -405K | 1.62M | 4.63M | 1.95M | -261.32K |
Operating Cash Flow | -69.71M | -62.6M | -57.95M | -55.88M | -57.47M | -52.07M | -48.23M | -45.9M | -41.98M | -45.86M | -47.8M | -45.26M | -41.7M | -33.68M | -24.49M | -17.39M | -11.6M |
Capital Expenditures | -527K | -552K | -686K | -412K | -266K | -267K | -119K | -341K | -573K | -576K | -1.21M | -1.45M | -1.5M | -2.43M | -1.72M | -1.25M | -960K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -138.24K | n/a | n/a | n/a | 138.24K |
Other Investing Acitivies | -194.24K | -198.24K | -218.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -218.24K | n/a | 138.24K | 138.24K | 356.48K | 138.24K |
Investing Cash Flow | -903.24K | -932.24K | -1.09M | -412K | -266K | -267K | -119K | -341K | -573K | -576K | -1.21M | -1.45M | -1.5M | -2.43M | -1.72M | -1.25M | -960K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 45K | 45K | 44.7K | -299 | -960 | -960 | 27.34K | 27.34K | 28K | 28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 47.73M | 47.88M | 73K | 100K | -386K | -508K | -209K | -244K | 74K | 55K | -882K | 90.84M | 90.23M | 90.22M | 91.18M | -545K | 55K |
Financial Cash Flow | 535K | 47.88M | 47.27M | 47.3M | 46.81M | 100.97M | 101.27M | 101.23M | 101.55M | 55K | -882K | 90.84M | 90.23M | 100.97M | 112.68M | 20.95M | 21.55M |
Net Cash Flow | -69.68M | -15.25M | -11.37M | -8.99M | -10.93M | 48.64M | 52.92M | 55M | 59M | -46.38M | -49.88M | 44.13M | 47.04M | 64.86M | 86.48M | 2.32M | 9M |
Free Cash Flow | -70.23M | -63.15M | -58.63M | -56.29M | -57.73M | -52.33M | -48.35M | -46.24M | -42.55M | -46.43M | -49M | -46.71M | -43.19M | -36.11M | -26.2M | -18.63M | -12.56M |